Skip to main content

Table 2 The clinical characteristics of patients’ classified according to MS

From: Association of CAPN10 haplotype combinations with type 2 diabetes mellitus and metabolic syndrome among Egyptians: pilot study—genotyping of three CAPN10 variants

Parameters

Patients with MS

Patients without MS

p

N (M/F)

38 (10/28)

11 (6/5)

X2 = 3.09 p = 0.078

Age (years)

53.1 ± 6.8

58.7 ± 11.3

Z = 1.65 p = 0.1

BMI (kg/m2)

32.5 ± 4.1

26.1 ± 5

Z = 3.72 p < 0.0001*

SBP (mmHg)

139.9 ± 26.3

108.2 ± 16

Z = 3.69 p < 0.0001*

DBP (mmHg)

86.7 ± 10.4

72.2 ± 10.1

Z = 3.38 p = 0.001*

FPG (mg/dl)

214.4 ± 101.1

199.9 ± 62.9

Z = 0.072 p = 0.943

HbA1c (%)

7.1 ± 1.6

7.2 ± 2.1

Z = 0.36 p = 0.719

Total Cholesterol (mg/dl)

164.7 ± 52.8

122.7 ± 63.6

Z = 2.109 p = 0.035*

Triglyceride (mg/dl)

140.8 ± 94

80.8 ± 31.3

Z = 2.385 p = 0.017*

HDL (mg/dl)

35.4 ± 12.9

36.8 ± 21.1

Z = 0.372 p = 0.71

LDL (mg/dl)

100.5 ± 39.4

66.6 ± 46.4

Z = 2.409 p = 0.016*

DD (years)

12.5 ± 7.8

8.4 ± 8.2

Z = 1.76 p = 0.078

T2DM family history (%)

22/38 (57.9)

4/11(36.4)

X2 = 1.59 p = 0.2

Hypertension (%)

26/38 (68.4)

2/11(18.2)

X2 = 8.79 p = 0.003*

  1. Bold indicates statistical significant result
  2. DD diabetes duration, BMI body mass index, GHb glycated hemoglobin, FPG fasting plasma glucose, SBP systolic blood pressure, DBP diastolic blood pressure, HDL-c high-density lipoprotein cholesterol and LDL-c low density lipoprotein cholesterol
  3. *Significant value at P < 0.05